- Home
- Publications
- Publication Search
- Publication Details
Title
Opportunities and challenges for anti-CD73 cancer therapy
Authors
Keywords
-
Journal
Immunotherapy
Volume 4, Issue 9, Pages 861-865
Publisher
Future Medicine Ltd
Online
2012-10-10
DOI
10.2217/imt.12.83
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Host A2B Adenosine Receptors Promote Carcinoma Growth
- (2015) Sergey Ryzhov et al. NEOPLASIA
- CD73 Participates in Cellular Multiresistance Program and Protects against TRAIL-Induced Apoptosis
- (2014) A. Mikhailov et al. JOURNAL OF IMMUNOLOGY
- Deficiency of CD73/ecto-5'-nucleotidase in mice enhances acute graft-versus-host disease
- (2012) H. Tsukamoto et al. BLOOD
- CD73-Deficient Mice Are Resistant to Carcinogenesis
- (2012) J. Stagg et al. CANCER RESEARCH
- Stat3 and Gfi-1 Transcription Factors Control Th17 Cell Immunosuppressive Activity via the Regulation of Ectonucleotidase Expression
- (2012) Fanny Chalmin et al. IMMUNITY
- High expression of CD73 as a poor prognostic biomarker in human colorectal cancer
- (2012) Xian-Rui Wu et al. JOURNAL OF SURGICAL ONCOLOGY
- CD73: a potent suppressor of antitumor immune responses
- (2012) Paul. A. Beavis et al. TRENDS IN IMMUNOLOGY
- A systematic analysis of experimental immunotherapies on tumors differing in size and duration of growth
- (2012) Frank T. Wen et al. OncoImmunology
- CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death
- (2011) S. Serra et al. BLOOD
- Disarming suppressor cells to improve immunotherapy
- (2011) Theresa L. Whiteside CANCER IMMUNOLOGY IMMUNOTHERAPY
- Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity
- (2011) Sebastian F. M. Häusler et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis
- (2011) J. Stagg et al. CANCER RESEARCH
- Inhibition of T-Cell Proliferation by Murine Multipotent Mesenchymal Stromal Cells is Mediated by CD39 Expression and Adenosine Generation
- (2011) Christine Sattler et al. CELL TRANSPLANTATION
- Altered purinergic signaling in CD73-deficient mice inhibits tumor progression
- (2011) Gennady G. Yegutkin et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Homing-associated molecules CD73 and VAP-1 as targets to prevent harmful inflammations and cancer spread
- (2011) Marko Salmi et al. FEBS LETTERS
- CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice
- (2011) Long Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Cancer Exosomes Express CD39 and CD73, Which Suppress T Cells through Adenosine Production
- (2011) A. Clayton et al. JOURNAL OF IMMUNOLOGY
- Adenosinergic Regulation of the Expansion and Immunosuppressive Activity of CD11b+Gr1+ Cells
- (2011) S. Ryzhov et al. JOURNAL OF IMMUNOLOGY
- Adenosine A2B Receptor Blockade Slows Growth of Bladder and Breast Tumors
- (2011) C. Cekic et al. JOURNAL OF IMMUNOLOGY
- CD73 (5′-nucleotidase) expression has no prognostic value in children with acute lymphoblastic leukemia
- (2011) E Wieten et al. LEUKEMIA
- NT5EMutations and Arterial Calcifications
- (2011) Cynthia St. Hilaire et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer
- (2011) Beat M. Künzli et al. Purinergic Signalling
- Mesenchymal stromal cells up-regulate CD39 and increase adenosine production to suppress activated T-lymphocytes
- (2011) Felipe Saldanha-Araujo et al. Stem Cell Research
- CD73 Expression as a Potential Marker of Good Prognosis in Breast Carcinoma
- (2011) Anna Supernat et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- CD73 on Tumor Cells Impairs Antitumor T-Cell Responses: A Novel Mechanism of Tumor-Induced Immune Suppression
- (2010) D. Jin et al. CANCER RESEARCH
- Tumor Cell Death and ATP Release Prime Dendritic Cells and Efficient Anticancer Immunity
- (2010) L. Aymeric et al. CANCER RESEARCH
- CD73: A Novel Target for Cancer Immunotherapy
- (2010) B. Zhang CANCER RESEARCH
- CD39/ENTPD1 Expression by CD4+Foxp3+ Regulatory T Cells Promotes Hepatic Metastatic Tumor Growth in Mice
- (2010) Xiaofeng Sun et al. GASTROENTEROLOGY
- Extracellular adenosine triphosphate and adenosine in cancer
- (2010) J Stagg et al. ONCOGENE
- Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
- (2010) J. Stagg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Involvement of Purinergic Signaling in Cellular Response to γ Radiation
- (2010) Mitsutoshi Tsukimoto et al. RADIATION RESEARCH
- Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments
- (2009) I. Kryczek et al. BLOOD
- Heightened NTPDase-1/CD39 expression and angiogenesis in radiation proctitis
- (2009) Sunil Sheth et al. Purinergic Signalling
- Tenascin C interacts with Ecto-5′-nucleotidase (eN) and regulates adenosine generation in cancer cells
- (2007) Rafal Sadej et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started